Page last updated: 2024-09-03

elacridar and Granulocytic Leukemia

elacridar has been researched along with Granulocytic Leukemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
den Ouden, D; Schoester, M; Sonneveld, P; van den Heuvel, M; van Rens, G1

Other Studies

1 other study(ies) available for elacridar and Granulocytic Leukemia

ArticleYear
In vitro effect of GF120918, a novel reversal agent of multidrug resistance, on acute leukemia and multiple myeloma cells.
    Leukemia, 1996, Volume: 10, Issue:12

    Topics: Acridines; Acute Disease; Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Resistance, Multiple; Humans; Isoquinolines; Kinetics; Leukemia, Myeloid; Multiple Myeloma; Neoplasm Proteins; Polymerase Chain Reaction; Rhodamine 123; Rhodamines; Tetrahydroisoquinolines; Transcription, Genetic; Tumor Cells, Cultured

1996
chemdatabank.com